管道中的各种药理学药物用于治疗难治性
Abdul Waris1, Muhammad Asim2,3, Ata Ullah1
1Department of Biomedical Sciences, City University of Hong Kong, Kowloon Tong, Hong Kong.
Archiv der Pharmazie
|May 20, 2024
概括
新的药正在开发中,用于治疗耐药性,这种疾病影响着数百万人. 研究人员正在探索超越当前药物的新目标和机制,以改善患者的治疗结果.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 是一种慢性神经系统疾病,在全球范围内患病率很高.
- 很大一部分患者 (30-35%) 患有耐药性,导致大量的死亡率.
- 现有的治疗方法对于相当数量的患者来说是不够的.
研究的目的:
- 审查药物和治疗不治性的其他治疗方案的管道.
- 在临床开发中确定新的药理学药剂和治疗策略.
- 总结新兴治疗方法的作用机制和目标.
主要方法:
- 在"ClinicalTrials.gov"上注册的临床试验的综合审查,用于难以治疗的.
- 药理学药剂和非药理学干预措施的识别和分类.
- 药物开发阶段,目标和作用机制的分析.
主要成果:
- 确定了31个治疗难治性的临床试验.
- 药物制剂占试验的48.4%,其中大多数在第二阶段 (60%).
- 与已批准的疗法相比,新兴药物表现出不同的作用机制和点.
结论:
- 对于难以治疗的来说,有大量的新型药理学药物的管道.
- 这些新药针对不同的途径,为改善治疗疗效提供了潜在的潜力.
- 非药物选择,如脑刺激和基因疗法也在调查中.
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
385
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
385
Antiepileptic Drugs: Glutamate Antagonists
320
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
320
Antiepileptic Drugs: Sodium Channel Blockers
511
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
511
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
286
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
286
Antiepileptic Drugs: Calcium Channel Blockers
373
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
373
Antiepileptic Drugs: Potassium Channel Activators
173
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
173


